Some of the limitations of existing pharmacotherapies for bipolar disorder are discussed on the slide.
References:
1. FDA website. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/. Accessed Jun 2014.
2. Yatham LN, Kennedy SH, Parikh SV, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018; 20 (2): 97–170.